These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 20546334)
1. Expression of HSP90 in gastrointestinal stromal tumours and mesenchymal tumours. Kang GH; Lee EJ; Jang KT; Kim KM; Park CK; Lee CS; Kang DY; Lee SH; Sohn TS; Kim S Histopathology; 2010 May; 56(6):694-701. PubMed ID: 20546334 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE; Kim MA; Lee HS; Lee BL; Kim WH J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383 [TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors. Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110 [TBL] [Abstract][Full Text] [Related]
4. Distribution of neural cell adhesion molecule (NCAM/CD56) in gastrointestinal stromal tumours and their intra-abdominal mesenchymal mimics. Agaimy A; Wünsch PH J Clin Pathol; 2008 Apr; 61(4):499-503. PubMed ID: 17923471 [TBL] [Abstract][Full Text] [Related]
5. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634 [TBL] [Abstract][Full Text] [Related]
6. WT-1 expression in gastrointestinal stromal tumours. Kang GH; Kim KM; Noh JH; Sohn TS; Kim S; Park CK; Lee CS; Kang DY Pathology; 2010 Jan; 42(1):54-7. PubMed ID: 20025481 [TBL] [Abstract][Full Text] [Related]
7. PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Pauls K; Merkelbach-Bruse S; Thal D; Büttner R; Wardelmann E Histopathology; 2005 Feb; 46(2):166-75. PubMed ID: 15693889 [TBL] [Abstract][Full Text] [Related]
8. Revision of gastrointestinal mesenchymal tumors. Sornmayura P; Howannapakorn J; Karnsombut P J Med Assoc Thai; 2009 Jan; 92(1):87-95. PubMed ID: 19260248 [TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours. Ryu MH; Kang YK; Jang SJ; Kim TW; Lee H; Kim JS; Park YH; Lee SS; Ryoo BY; Chang HM; Lee JL; Yook JH; Kim BS; Lee JS Histopathology; 2007 Sep; 51(3):379-89. PubMed ID: 17727479 [TBL] [Abstract][Full Text] [Related]
11. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib. Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246 [TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors (GISTs): a pathology view point. Sornmayura P J Med Assoc Thai; 2009 Jan; 92(1):124-35. PubMed ID: 19260254 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumours. Miettinen M; Sarlomo-Rikala M; Lasota J Ann Chir Gynaecol; 1998; 87(4):278-81. PubMed ID: 9891765 [TBL] [Abstract][Full Text] [Related]
14. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of connexin 43 in gastrointestinal stromal tumours of gastric and small intestinal origin. Nishitani A; Hirota S; Nishida T; Isozaki K; Hashimoto K; Nakagomi N; Matsuda H J Pathol; 2005 Aug; 206(4):377-82. PubMed ID: 15938003 [TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
17. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M; Wang ZF; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
19. Revision of gastrointestinal mesenchymal tumours with CD117. de Schipper JP; Liem RS; van den Ingh HF; van der Harst E Eur J Surg Oncol; 2004 Nov; 30(9):959-62. PubMed ID: 15498641 [TBL] [Abstract][Full Text] [Related]
20. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]